Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 6, 2006, Pages 1959-1966

  Le Carrou, J ^a   Laurentie, M ^a   Kobisch, M ^a   Gautier Bouchardon, A V ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; MARBOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG PENETRATION; EXPERIMENTAL INFECTION; GENE; GENE MUTATION; MOLECULAR CLONING; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PARC GENE; POINT MUTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; SWINE; WILD TYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMA INFECTIONS; OXYTETRACYCLINE; QUINOLONES; SEQUENCE ANALYSIS, DNA; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; TRACHEA; TRACHEAL DISEASES;

EID: 33744485824     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01527-05     Document Type: Article

References (54)

1. Balaban, N. Q., J. Merrin, R. Chait, L. Kowalik, and S. Leibler. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
2. Bébéar, C., and J. A. Robertson. 1996. Determination of minimal inhibitory concentrations, p. 189-197. In J. G. Tully and S. Razin (ed.), Molecular and diagnostic procedures in mycoplasmology, vol. II. Diagnostic procedures. Academic Press, New York, N.Y.
3. Cariolet, R., and J. P. Tillon. 1978. La reproduction de porcelets exempts d'organismes pathogènes spécifiques (EOPS) à la Station de Pathologie Porcine de Ploufragan. Sci. Tech. Animal Lab. 3:213-225.
4. Centre de recherche Vétoquinol. 1999. Dossier d'enregistrement de Marbocyl. [Online.] http://www.marbocyl.com/fr/.
5. Chambaud, I., R. Heilig, S. Ferris, V. Barbe, D. Samson, F. Galisson, I. Moszer, K. Dybvig, H. Wroblewski, A. Viari, E. P. Rocha, and A. Blanchard. 2001. The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis. Nucleic Acids Res. 29:2145-2153.
6. Combet, C., C. Blanchet, C. Geourjon, and G. Deléage. 2000. NPS@: Network Protein Sequence Analysis. Trends Biochem. Sci. 25:147-150.
7. Dallo, S. F., and J. B. Baseman. 2000. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb. Pathog. 29:301-309.
8. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
9. Friis, N. F. 1974. Mycoplasma suipneumoniae and Mycoplasma flocculare in comparative pathogenicity studies. A survey. Nord. Vetmed. 15:507-518.
10. Friis, N. F. 1975. Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare. A survey. Nord. Vetmed. 27:337-339.
11. Garnier, J. M., G. Noel, K. Retornaz, P. Blanc, and P. Minodier. 2005. Extrapulmonary infections due to Mycoplasma pneumoniae. Arch. Pediatr. 1:S2-S6.
12. Gautier-Bouchardon, A. V., A. K. Reinhardt, M. Kobisch, and I. Kempf. 2002. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet. Microbiol. 88:47-58.
13. Goodwin, R. F. W. 1985. Apparent reinfection of enzootic-pneumonia-free pig herds: search for possible causes. Vet. Rec. 116:690-694.
14. Goodwin, R. F. W., A. P. Pomeroy, and P. Wittlestone. 1965. Production of enzootic pneumonia in pigs with a mycoplasma. Vet. Rec. 77:1247-1249.
15. Hannan, P. C. T. 1990. Treatment of experimental enzootic pneumonia of the pig by norfloxacin or its 6-chloro analogue. Res. Vet. Sci. 49:203-210.
16. Hannan, P. C. T., G. D. Windsor, A. de Jong, N. Schmeer, and M. Stegemann. 1997. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob. Agents Chemother. 41:2037-2040.
17. Hannan, P. C. T., H. M. Windsor, and P. H. Ripley. 1997. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res. Vet. Sci. 63:157-160.
18. Hannan, P. C. T., P. J. O'Hanlon, and N. H. Rogers. 1989. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Res. Vet. Sci. 46:202-211.
19. Himmelreich, R., H. Hilbert, H. Plagens, E. Pirkl, B. C. Li, and R. Herrmann. 1996. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 24:4420-4449.
20. Hirose, K., Y. Kawasaki, K. Kotani, K. Abiko, and H. Sato. 2004. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance. J. Vet. Med. B 51:169-175.
21. Hooper, D. C. 1999. Mechanisms of fluoroquinolone resistance. Drug Resist. Updates 2:38-55.
22. Kellog, D. E., and S. Kwok. 1990. Detection of human immunodeficiency virus, p 339-343. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
23. Keren, I., N. Kaldalu, A. Spoering, Y. Wang, and K. Lewis. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
24. Kobisch, M., and C. Sibelle. 1982. Evaluation de l'efficacité de la tiamuline chez des porcelets infectés expérimentalement par Mycoplasma hyopneumoniae. Recl. Med. Vet. 158:375-381.
25. Kobisch, M., and N. F. Friis. 1996. Swine mycoplasmoses. Rev. Sci. Tech. 15:1569-1605.
26. Le Carrou, J., A. K. Reinhardt, I. Kempf, and A. V. Gautier-Bouchardon. 2006. Persistence of Mycoplasma synoviae in hens after two enrofloxacin treatments and detection of mutations in the parC gene. Vet. Res. 37:145-154.
27. Madec, F., and H. Derrien. 1981. Fréquence, intensité et localisation des lésions pulmonaires chez le porc charcutier. Journ. Rech. Porcine France 13:231-236.
28. Marois, C., F. Dufour-Gesbert, and I. Kempf. 2000. Detection of Mycoplasma synoviae in poultry environment samples by culture and polymerase chain reaction. Vet. Microbiol. 73:311-318.
29. Martinez, M., P. McDermott, and R. Walker. 2005. Pharmacology of the fluoroquinolones: a perspective for use in domestic animals. Vet. J., in press.
30. Maurin, M., N. F. Mersali, and D. Raoult. 2000. Bactericidal activities of antibiotics against intracellular Francisella tularensis. Antimicrob. Agents Chemother. 44:3428-3431.
31. Maxwell, A., and S. E. Critchlow. 1998. Mode of action, p 120-166. In J. Kuhlmann, A. Dalhoff, and H. J. Zeiler (ed.), Handbook of experimental pharmacology: quinolone antibacterials. Springer-Verlag, Berlin, Germany.
32. Minion, F. C., E. J. Lefkowitz, M. L. Madsen, B. J. Cleary, S. M. Swartzell, and G. G. Mahairas. 2004. The genome sequence of Mycoplasma hyopneumoniae strain 232, the agent of swine mycoplasmosis. J. Bacteriol. 186:7123-7133.
33. Much, P., F. Winner, L. Stipkovits, R. Rosengarten, and C. Citti. 2002. Mycoplasma gallisepticum: influence of cell invasiveness on the outcome of experimental infection in chickens. FEMS Immunol. Med. Microbiol. 34:181-186.
34. Nilius, A. M., L. L. Shen, D. Hensey-Rudloff, L. S. Almer, J. M. Beyer, D. J. Balli, Y. Cai, and R. K. Flamm. 2003. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrob. Agents Chemother. 47:3260-3269.
35. Pellet, T., M. Gicquel-Bruneau, P. Sanders, and M. Laurentie. 2005. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli. Res. Vet. Sci. 80:324-335.
36. Piddock, L. J. V. 1999. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 2:11-18.
37. Piddock, L. J. V., and M. M. Jonhson. 2002. Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:813-820.
38. Reinhardt, A. K., A. V. Gautier-Bouchardon, M. Gicquel-Bruneau, M. Kobisch, and I. Kempf. 2005. Persistence of Mycoplasma gallisepticum in chickens after treatment with enrofloxacin, without resistance development. Vet. Microbiol. 106:129-137.
39. Reinhardt, A. K., C. M. Bébéar, M. Kobisch, I. Kempf, and A. V. Gautier-Bouchardon. 2002. Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrob. Agents Chemother. 46:590-593.
40. Reinhardt, A. K., I. Kempf, M. Kobisch, and A. V. Gautier-Bouchardon. 2002. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level. J. Antimicrob. Chemother. 50:589-592.
41. Roch, N., and M. Maurin. 2005. Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay. J. Antimicrob. Chemother. 55:866-871.
42. Ross, R. F. 1988. Evaluation of tiamulin for treatment of mycoplasmal pneumonia in swine. J. Am. Vet. Med. Assoc. 193:441-446.
43. Ross, R. F. 1999. Mycoplasmal diseases, p. 537-551. In B. E. Straw, S. D'allairc, W. L. Mengeling, and D. J. Taylor (ed.), Diseases of swine, 8th ed. Iowa State University Press, Ames, Iowa.
44. SAS Institute. 1999. SAS/STAT user's guide, version 8. SAS Institute Inc., Cary, N.C.
45. Schmitz, F. J., M. E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Luckefahr, A. Fluit, J. Verhoef, U. Hadding, H. P. Heinz, and K. Kohrer. 1998. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252.
46. Schneider, M., V. Thomas, B. Boisrame, and J. Deleforge. 1996. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. J. Vet. Pharmacol. Ther. 19:56-61.
47. Seral, C., M. Barcia-Macay, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2005. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J. Antimicrob. Chemother. 55:511-517.
48. Stärk, K. D., J. Nicolet, and J. Frey. 1998. Detection of Mycoplasma hyopneumoniae by air sampling with a nested PCR assay. Appl. Environ. Microbiol. 64:543-548.
49. Vicca, J., D. Maes, L. Jonker, A. de Kruif, and F. Haesebrouck. 2005. Efficacy of in-feed medication with tylosin for the treatment and control of Mycoplasma hyopneumoniae infections. Vet. Rec. 156:606-610.
50. Wang, T., M. Tanaka, and K. Sato. 1998. Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob. Agents Chemother. 42:236-240.
51. Whittlestone, P. 1979. Porcine mycoplasmas, p. 133-176. In J. G. Tully and R. F. Whitcomb (ed.), The mycoplasmas, 1st ed., vol II. Academic Press, New York, N.Y.
52. Winner, F., R. Rosengarten, and C. Citti. 2000. In vitro cell invasion of Mycoplasma gallisepticum. Infect. Immun. 68:4238-4244.
53. Yavlovich, A., M. Tarshis, and S. Rottem. 2004. Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells. FEMS Microbiol. Lett. 233:241-246.
54. Yokoyama, K., K. Makino, Y. Kubota, M. Watanabe, S. Kimura, C. H. Yutsudo, K. Kurokawa, K. Ishii, M. Hattori, H. Abe, T. Iida, K. Yamamoto, T. Hayashi, T. Yasunaga, T. Honda, C. Sasakawa, and H. Shinagawa. 2000. Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak. Gene 258:127-139.